Validating mitochondrial electron transport chain content in individuals at clinical high risk for psychosis

Area of Science:

• Neuroscience
• Cellular Biology
• Psychiatry

Background:

• Mitochondrial electron transport chain (ETC) dysfunction is hypothesized to contribute to schizophrenia's development.
• Previous research indicated no ETC alterations in white blood cells of individuals at clinical high risk for psychosis.

Purpose of the Study:

• To replicate and validate findings of unaltered mitochondrial complex I-V content in a new cohort of individuals at clinical high risk for psychosis.
• To investigate correlations between mitochondrial complex levels and psychosis prodrome symptoms.

Main Methods:

• Analysis of mitochondrial complex I-V content in peripheral blood mononuclear cells from two independent cohorts of individuals at clinical high risk for psychosis.
• Statistical analysis to compare complex levels between groups and correlate with symptom severity.

Main Results:

• Replication of the initial finding: no significant differences in mitochondrial complex I-V content were observed in the validation cohort.
• Combined analysis of both cohorts confirmed the lack of differential mitochondrial complex levels.
• Identified significant correlations between mitochondrial complex III and negative symptoms, and complex V and disorganization symptoms.

Conclusions:

• Mitochondrial electron transport chain dysfunction is not a detectable feature in the peripheral blood of individuals in the prodromal stage of schizophrenia.
• While overall ETC function appears intact, specific complex levels may correlate with certain symptom domains in early psychosis.